Which alpha-2 delta ligands are approved for neuropathic pain treatment?

Enhance your preparation for the PMHNP Certification Exam with Georgette's resources. Delve into multiple-choice questions and detailed explanations to ensure you're ready for success. Boost your study efficiency and exam confidence today!

Multiple Choice

Which alpha-2 delta ligands are approved for neuropathic pain treatment?

Explanation:
Alpha-2 delta ligands work by binding to the alpha-2 delta subunit of voltage-gated calcium channels, which reduces excitatory neurotransmitter release and dampens abnormal nerve signaling in neuropathic pain. The two drugs in this category that are approved for neuropathic pain are gabapentin and pregabalin (brand name Lyrica). Gabapentin and pregabalin are specifically indicated for neuropathic pain conditions like postherpetic neuralgia and diabetic neuropathy. Other anticonvulsants listed act through different mechanisms (for example, lamotrigine and carbamazepine primarily block sodium channels) and are not alpha-2 delta ligands approved for neuropathic pain.

Alpha-2 delta ligands work by binding to the alpha-2 delta subunit of voltage-gated calcium channels, which reduces excitatory neurotransmitter release and dampens abnormal nerve signaling in neuropathic pain. The two drugs in this category that are approved for neuropathic pain are gabapentin and pregabalin (brand name Lyrica). Gabapentin and pregabalin are specifically indicated for neuropathic pain conditions like postherpetic neuralgia and diabetic neuropathy.

Other anticonvulsants listed act through different mechanisms (for example, lamotrigine and carbamazepine primarily block sodium channels) and are not alpha-2 delta ligands approved for neuropathic pain.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy